Auna SA AUNA · NYSE
$4.99 -3.29% (-$0.17)
Summary
51 / 100 · Bulios Score
What speaks for it
- Revenue grew by 21% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- Out of every 100 PEN of revenue, 11 PEN is left as free cash.
What to watch
- Repaying its net debt would take 4.6 years of operating profit.
- Out of every 100 PEN of revenue, only 0.3 PEN is left as net profit.
- It earns only 3.7 PEN a year on every 100 PEN of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 82.7 PEN for 1 PEN of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (PEN)
Diluted EPS (PEN)
- Analyst estimate
Revenue grew by 25% a year over 5 years. Over the last 3 years it grew by 21% a year.
Growth in detailDoes it make money?
ReasonablyWhere 100 PEN of revenue goes
- Cost of sales 63 PEN
- Sales and administration 24 PEN
- Taxes and other 13 PEN
- Net profit 0.3 PEN
Net profit, industry median (Medical - Care Facilities) 6.8 PEN
Out of every 100 PEN of revenue, 0.3 PEN is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 7.4 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 1
- Sell 0
Today's price within the analysts' price targets
The average target of $11.92 is 139% above today's price. 0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Healthcare services 100%
By region
- PERU 44%
- COLOMBIA 33%
- MEXICO 24%
Healthcare services brings in 100% of revenue.
Segments in detail